Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jieting Peng

HDAC Inhibitors as Antifibrotic Drugs in Cardiac and Pulmonary Fibrosis

Therapeutic Advances in Chronic Disease

English

Related publications

Idiopathic Pulmonary Fibrosis (IPF) ― Common Practice in Poland Before the “Antifibrotic Drugs Era”

Advances in Respiratory Medicine

Respiratory Medicine

English

HDAC Inhibitors in Experimental Liver and Kidney Fibrosis

Fibrogenesis and Tissue Repair

Gastroenterology

English

FRI0461 Efficacy and Safety of Antifibrotic Agents in Idiopathic Pulmonary Fibrosis

English

Emerging Drugs for Idiopathic Pulmonary Fibrosis

Expert Opinion on Emerging Drugs

English

Impact of Novel Antifibrotic Therapy on Patient Outcomes in Idiopathic Pulmonary Fibrosis: Patient Selection and Perspectives

Patient Related Outcome Measures

English

Pretreatment With G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis

Stem Cells International

Molecular Biology

English

HDAC Inhibitors Show Benefits in Breast Cancer

Cancer Discovery

English

Comparison of HDAC Inhibitors in Clinical Development

Human Vaccines and Immunotherapeutics

English

Mucins as a New Frontier in Pulmonary Fibrosis

Journal of Clinical Medicine

English